Federal Circuit rules ‘treatment claims’ are patent eligible

18-03-2019

Federal Circuit rules ‘treatment claims’ are patent eligible

felixlipov / Shutterstock.com

The US Court of Appeals for the Federal Circuit has warned against implementing “too broad” an interpretation of the Alice test as it ruled that “treatment claims” were eligible for patenting.


Alice/Mayo, US Court of Appeals for the Federal Circuit, Creative Compounds, Natural Alternatives, vitamins, supplements, patent infringement

LSIPR